AI Article Synopsis
- Epithelial ovarian cancer is the most prevalent type, primarily affecting women over 50, and is often diagnosed at advanced stages (III or IV), leading to a poor prognosis.
- Treatment typically involves a combination of surgery and chemotherapy, which is crucial for both early and advanced cases.
- Recent years have seen the introduction of several new drugs for treatment, with ongoing research into novel targets and agents for improved outcomes.
Article Abstract
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.canlet.2011.01.026 | DOI Listing |
Publication Analysis
Top Keywords
ovarian cancer
20
epithelial ovarian
8
treatment ovarian
8
ovarian
5
cancer
5
chemotherapy epithelial
4
cancer epithelial
4
cancer common
4
common type
4
type ovarian
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!